Gland Pharma vs Anthem Biosciences vs Ipca Labs: Which Stock Should You Track

Gland Pharma vs Anthem Biosciences vs Ipca Laboratories starts with the core numbers most investors compare within the Pharma and Biotech segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of October 2026 and will shift with daily price moves.

All three names sit in the Pharma and Biotech bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.

Click Here – Get Free Investment Predictions

Gland Pharma, Anthem Biosciences and Ipca Laboratories: Company Overview

Gland Pharma is a listed Indian company in the Pharma and Biotech space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Anthem Biosciences is a listed Indian company in the Pharma and Biotech space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Ipca Laboratories is a listed Indian company in the Pharma and Biotech space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.

Gland Pharma vs Anthem Biosciences vs Ipca Laboratories: Valuation and Profitability Snapshot

Metric	Gland Pharma	Anthem Biosciences	Ipca Laboratories
Market Cap (approx.)	Rs 48,107 crore	Rs 49,081 crore	Rs 50,543 crore
PE Ratio (TTM)	42.62	85.25	36.76
PB Ratio	4.64	16.13	6.27
Return on Equity (ROE)	9.92%	19.45%	14.15%
EPS (TTM, Rs)	68.41	10.22	54.20
Dividend Yield	0.69%	0.23%	0.30%
Debt to Equity	0.03	0.02	0.10
Book Value per Share (Rs)	627.71	54.01	317.84

Check the Univest Screener for Live Data

On valuation, Gland Pharma trades at a PE of 42.62 and a PB of 4.64, Anthem Biosciences at a PE of 85.25 and a PB of 16.13, while Ipca Laboratories trades at a PE of 36.76 and a PB of 6.27. On return on equity, the three post 9.92%, 19.45% and 14.15% respectively, and on dividend yield they stand at 0.69%, 0.23% and 0.30%.

Gland Pharma vs Anthem Biosciences vs Ipca Laboratories: Latest Quarterly Results

Company	Latest Quarter Revenue	Latest Quarter Net Profit	YoY Change (Revenue)	QoQ Change (Revenue)
Gland Pharma	Rs 1,861.50 crore	Rs 316.96 crore	+19.1%	+0.4%
Anthem Biosciences	Rs 443.11 crore	Rs 119.94 crore	-21.3%	-33.1%
Ipca Laboratories	Rs 2,813.36 crore	Rs 422.81 crore	+20.2%	+13.3%

Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.

Download the Univest iOS App or Univest Android App to track Gland Pharma, Anthem Biosciences and Ipca Laboratories live prices.

What Should Investors Look at Beyond These Numbers?

Beyond the metrics above, investors comparing these three pharma and biotech names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.

Conclusion

Gland Pharma vs Anthem Biosciences vs Ipca Laboratories highlights how differently three companies in the same pharma and biotech segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.

FAQs on Gland Pharma vs Anthem Biosciences vs Ipca Laboratories

What is the market cap difference between Gland Pharma, Anthem Biosciences and Ipca Laboratories?

Ans. As of October 2026, Gland Pharma has a market cap of approximately Rs 48,107 crore, Anthem Biosciences is at approximately Rs 49,081 crore, and Ipca Laboratories is at approximately Rs 50,543 crore.

Which of the three has the highest PE ratio?

Ans. Among Gland Pharma, Anthem Biosciences and Ipca Laboratories, the PE ratios stand at 42.62, 85.25 and 36.76 respectively as of October 2026.

Which of the three has the highest ROE?

Ans. Gland Pharma, Anthem Biosciences and Ipca Laboratories post ROE of 9.92%, 19.45% and 14.15% respectively as of October 2026.

Which of these three stocks pays the highest dividend yield?

Ans. Gland Pharma, Anthem Biosciences and Ipca Laboratories carry dividend yields of 0.69%, 0.23% and 0.30% respectively.

What is the debt to equity ratio for Gland Pharma, Anthem Biosciences and Ipca Laboratories?

Ans. Gland Pharma carries a debt to equity of 0.03, Anthem Biosciences of 0.02, and Ipca Laboratories of 0.10.

Which of the three trades at the highest price to book value?

Ans. Gland Pharma, Anthem Biosciences and Ipca Laboratories trade at price to book ratios of 4.64, 16.13 and 6.27 respectively.

Is one of Gland Pharma, Anthem Biosciences or Ipca Laboratories better than the others?

Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.